Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FGH8Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,670
Award facts
- Contract value 100% obligated
- $10,669.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,669.94 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen (2 mL) on October 22, 2025, with an ultimate completion date of October 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant portfolio of federal medical contracts supplying a broad range of pharmaceutical products and medical supplies to defense and veteran healthcare systems. The Dupixent delivery under this contract supports the Defense Health Agency and other federal healthcare customers through AmerisourceBergen's extensive capability to fulfill specialized pharmaceutical procurement needs. As a prime contractor on the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen competes alongside other vendors to provide critical medical commodities including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support U.S. military personnel and beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DR26FGH8Q?
SPE2DR26FGH8Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DR26FGH8Q worth?
The government has obligated $10,670 on SPE2DR26FGH8Q.
Is contract SPE2DR26FGH8Q an order under another contract?
Yes. SPE2DR26FGH8Q is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGH8Q competed?
The extent of competition for SPE2DR26FGH8Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award